Clinical trial · Interventional
Tight Glycemic Control by Artificial Pancreas
Continuous Postoperative Blood Glucose Monitoring and Control by an Artificial Pancreas in Patients Undergoing Pancreatic Resection: A Prospective Randomized Clinical Trial
NCT00657995CI-TRIAL-00001403completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study evaluated a closed-loop system providing continuous monitoring and strict control of perioperative blood glucose following pancreatic resection.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Neoplasm | Pancreatic Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Artificial Pancreas (STG-22) | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- 2
- description
- Thirty patients who underwent pancreatic resection for pancreatic neoplasm were prospectively randomized. Perioperative blood glucose levels were continuously monitored using an artificial endocrine pancreas (STG-22). Glucose levels were controlled using either the sliding scale method or the artificial pancreas.
- interventionNames
- Device: Artificial Pancreas (STG-22)
Primary outcomes (1)
- measure
- the incidence of severe hypoglycemia (< 40 mg/dl) during the intensive care period following pancreatic resection in patients monitored using the artificial pancreas
- timeFrame
- the first postoperative 18 hours in the surgical intensive care unit
Secondary outcomes (1)
- measure
- the total amount of insulin required for glycemic control after pancreatic resection
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * This study recruited 32 patients undergoing elective pancreatic resection for pancreatic disease. Exclusion Criteria: * weight loss greater than 10% during the previous 6 months * signs of distant metastasis * respiratory, renal,or heart disease * Patients provided written informed consent prior to enrollment
References
Publications (0)
Data not yet available
No reference posted for this study.